Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04963153 |
| Title | Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | National Cancer Institute (NCI) |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Los Angeles County-USC Medical Center | Recruiting | Los Angeles | California | 90033 | United States | Details |
| USC / Norris Comprehensive Cancer Center | Recruiting | Los Angeles | California | 90033 | United States | Details |
| Moffitt Cancer Center | Recruiting | Tampa | Florida | 33612 | United States | Details |
| University of Pittsburgh Cancer Institute (UPCI) | Recruiting | Pittsburgh | Pennsylvania | 15232 | United States | Details |
| Huntsman Cancer Institute/University of Utah | Suspended | Salt Lake City | Utah | 84112 | United States | Details |